Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of
which can produce disease in humans of all ages and can affect both pulmonary and …

This article reviews approaches to studying the epidemiology of nontuberculous
mycobacteria (NTM)-related pulmonary disease (NTM PD), and updates in the field since …

A significant knowledge gap exists concerning the geographical distribution of nontuberculous
mycobacteria (NTM) isolation worldwide. To provide a snapshot of NTM species …

Nontuberculous have been recognized since the late nineteenth century [1], not long after
Robert Koch’s discovery of the tubercle bacillus. The recognition of the presence of these …

Background: The prevalence of pulmonary non-tuberculous mycobacteria (NTM) infection is
reportedly increasing. A study was undertaken of the “isolation prevalence” of pulmonary …

Background Severe Acute Respiratory Syndrome (SARS) became a global epidemic in
2003. Comprehensive information on 1-year outcomes and health care utilization is lacking. …

Rationale: Improved therapeutic options are needed for patients with treatment-refractory
nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex (MAC). …

We measured the prevalence and temporal trends of pulmonary nontuberculous mycobacterial
disease among residents of Ontario, Canada, during 1998–2010. Five-year prevalence …

Rationale: Estimating the annual incidence and prevalence of nontuberculous mycobacterial
(NTM) lung disease may assist in improving understanding of the public health and …

The 2020 clinical practice guideline for the treatment of non-tuberculous mycobacterial
pulmonary disease (NTM-PD) by the American Thoracic Society, European Respiratory Society, …